A Paclitaxel Prodrug Activatable by Irradiation in a Hypoxic Microenvironment
- 27 August 2020
- journal article
- research article
- Published by Wiley in Angewandte Chemie
- Vol. 132 (51) , 23398-23405
Abstract
The innate hypoxic microenvironment of most solid tumors has a major influence on tumor growth, invasiveness, and distant metastasis. Here, a hypoxia‐activated self‐immolative prodrug of paclitaxel (PTX2‐Azo) was synthesized and encapsulated by a peptide copolymer decorated with the photosensitizer chlorin e6 (Ce6) to prepare light‐boosted PTX nanoparticle (Ce6/PTX2‐Azo NP). In this nanoparticle, PTX2‐Azo prevents premature drug leakage and realizes specific release in hypoxic tumor microenvironment and the photosensitizer Ce6 not only efficiently generates singlet oxygen under light irradiation but also acts as a positive amplifier to promote the release of PTX. The combination of photodynamic therapy (PDT) and chemotherapy results in excellent antitumor efficacy, demonstrating the great potential for synergistic cancer therapy.Keywords
Funding Information
- National Natural Science Foundation of China (51773197, 51973213 and 51973214)
This publication has 64 references indexed in Scilit:
- GSH and H2O2 Co‐Activatable Mitochondria‐Targeted Photodynamic Therapy under Normoxia and HypoxiaAngewandte Chemie International Edition, 2020
- Improving cancer therapy through the nanomaterials-assisted alleviation of hypoxiaBiomaterials, 2020
- Selectively Potentiating Hypoxia Levels by Combretastatin A4 Nanomedicine: Toward Highly Enhanced Hypoxia‐Activated Prodrug Tirapazamine Therapy for Metastatic TumorsAdvanced Materials, 2019
- Innovative Strategies for Hypoxic‐Tumor Photodynamic TherapyAngewandte Chemie International Edition, 2018
- Innovative Strategien für die photodynamische Therapie hypoxischer TumoreAngewandte Chemie, 2018
- Targeting hypoxia in cancer therapyNature Reviews Cancer, 2011
- Activatable Photosensitizers for Imaging and TherapyChemical Reviews, 2010
- Photodynamic therapy for cancerNature Reviews Cancer, 2003
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular AspectsJNCI: Journal of the National Cancer Institute, 2001